SENNA- sennosides tablet 
PHARMACY VALUE ALLIANCE LLC

----------

pva 451B

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Warnings

Do not use

for more than one week unless directed by a doctor.

Ask a doctor before use if you
• have stomach pain, nausea or vomiting
• have noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor



Other information

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, silica, talc, triacetin

Package Label

1

SENNA 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-832
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
TALC (UNII: 7SEV7J4R1U)  
TRIACETIN (UNII: XHX3C3X673)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize9mm
FlavorImprint Code PS23
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-832-01100 in 1 BOTTLE; Type 0: Not a Combination Product12/01/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)12/01/2022
Labeler - PHARMACY VALUE ALLIANCE LLC (101668460)
Registrant - Geri-Care Pharmaceutical Corp (611196254)

Revised: 12/2023
Document Id: 0bdc20a9-7921-9a06-e063-6394a90a84cc
Set id: 0a3502f3-f83d-0417-e063-6294a90a88a1
Version: 2
Effective Time: 20231206
 
PHARMACY VALUE ALLIANCE LLC